Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) have earned a consensus broker rating score of 2.00 (Buy) from the two analysts that cover the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold recommendation and one has assigned a strong buy recommendation to the company. Brokerages have set a […]
